Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets

26 May 2015

Abstract excerpt

BACKGROUND: The bacterium Corynebacterium pseudotuberculosis (Cp) causes caseous lymphadenitis (CLA), mastitis, ulcerative lymphangitis, and oedema in a number of hosts, comprising ruminants, thereby intimidating economic and dairy industries worldwide. So far there is no effective drug or vaccine available against Cp. Previously, a pan-genomic analysis was performed for both biovar equi and biovar ovis and a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diphtheria, Corynebacterium, and Tetanus
Share to Mycobacterium research and diagnosis
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26041381
DOI: 10.1186/1471-2164-16-s5-s9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targetsPMID 26041381Read ↗

A Novel Comparative Genomics Analysis for Common Drug and Vaccine Targets in<i>Corynebacterium pseudotuberculosis</i>and other CMN Group of Human PathogensSemantic proximity Read ↗

An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriaeSemantic proximity Read ↗

Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug TargetsSemantic proximity Read ↗

PBITV3 : A robust and comprehensive tool for screening pathogenic proteomes for drug targets and prioritizing vaccine candidatesSemantic proximity Read ↗

Prediction of new vaccine targets in the core genome of Corynebacterium pseudotuberculosis through omics approaches and reverse vaccinologySemantic proximity Read ↗

Label-free quantitative proteomics of Corynebacterium pseudotuberculosis isolates reveals differences between Biovars ovis and equi strainsSemantic proximity Read ↗

The pan-genome of the animal pathogen Corynebacterium pseudotuberculosis reveals differences in genome plasticity between the biovar ovis and equi strains.Semantic proximity Read ↗

Assessing the Genotypic Differences between Strains of Corynebacterium pseudotuberculosis biovar equi through Comparative Genomics.Semantic proximity Read ↗

Genome-wide Core Proteome Analysis of Brucella melitensis Strains for Potential Drug Target PredictionSemantic proximity Read ↗

Genome sequence of Corynebacterium pseudotuberculosis biovar equi strain 258 and prediction of antigenic targets to improve biotechnological vaccine productionSemantic proximity Read ↗

Genome-Based Drug Target Identification in Human Pathogen Streptococcus gallolyticusSemantic proximity Read ↗

PROGRESSION OF ‘OMICS’ METHODOLOGIES FOR UNDERSTANDING THE PATHOGENICITY OF <i>CORYNEBACTERIUM PSEUDOTUBERCULOSIS</i> : THE BRAZILIAN EXPERIENCESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.